New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 24, 2012
08:04 EDTRPTPRaptor Pharma weakness may provide buying opporutnity, says Oppenheimer
After Raptor announced that the FDA had postponed its decision on approving Raptor's Procysbi for three months until April 30, 2013, Oppneheimer views the news as a short-term negative for the company but doesn't think it has any implication on the FDA's ultimate decision about Procysbi. The firm maintains an Outperform rating on Raptor.
News For RPTP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
10:54 EDTRPTPRaptor Pharmaceuticals management to meet with JMP Securities
Subscribe for More Information
February 26, 2015
18:43 EDTRPTPOn The Fly: After Hours Movers
Subscribe for More Information
16:32 EDTRPTPRaptor Pharmaceuticals sees FY15 net sales of PROCYSBI $80M-$90M
Subscribe for More Information
16:30 EDTRPTPRaptor Pharmaceuticals reports Q4 adjusted EPS (25c), consensus (14c)
Subscribe for More Information
February 23, 2015
10:17 EDTRPTPOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use